Suchergebnisse - "Brüggemann, Roger J M"

PubPharm (169)

1

Development and validation of an UPLC-MS/MS assay for the simultaneous quantification of seven commonly used antibiotics in human plasma and its application in therapeutic drug monitoring

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Mekking, X. | Velthoven-Graafland, K. | Teulen, M. | +3

2

Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole

enthalten in: Clinical pharmacokinetics | 2024

von Jansen, A. | Snijdelaar, K. | Keizer, R. | +4

3

Evaluation of the drug-drug interaction between triazole antifungals and cystic fibrosis transmembrane conductance regulator modulators in a real-life cohort

enthalten in: Medical mycology | 2024

von Jansen, A. | Eggermont, M. | Wilms, E. | +6

4

How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400-600 mg·h/L-Targeted Dosing

enthalten in: Clinical pharmacokinetics | 2024

von Zhang, T. | Krekels, E. | Smit, C. | +3

5

High Variability in Isavuconazole Unbound Fraction in Clinical Practice : A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints

enthalten in: Clinical pharmacokinetics | 2023

von Jansen, A. | Ter Heine, R. | Verweij, P. | +1

CommentIn: Clin Pharmacokinet. 2024 Apr 4;:. - PMID 38573478

6

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients : Implications for Adaptive Dosing Strategies

enthalten in: Clinical pharmacokinetics | 2023

von Jansen, A. | Mertens, B. | Spriet, I. | +6

CommentIn: Clin Pharmacokinet. 2024 Apr 4;:. - PMID 38573478

7

Pharmacokinetic investigations of isavuconazole in paediatric cancer patients show reduced exposure of isavuconazole after opening capsules for administration via a nasogastric tube

enthalten in: The Journal of antimicrobial chemotherapy | 2023

von Bury, D. | Wolfs, T. | Ter Heine, R. | +4

8

How to Dose Vancomycin in Overweight and Obese Patients with Varying Renal (Dys)function in the Novel Era of AUC 400–600 mg·h/L-Targeted Dosing

enthalten in: Clinical pharmacokinetics | 2023

von Zhang, T. | Krekels, E. | Smit, C. | +3

9

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies

enthalten in: Clinical pharmacokinetics | 2023

von Jansen, A. | Mertens, B. | Spriet, I. | +6

10

High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints

enthalten in: Clinical pharmacokinetics | 2023

von Jansen, A. | ter Heine, R. | Verweij, P. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]